{"id":"https://openalex.org/W2570554665","doi":"https://doi.org/10.1182/blood.v122.21.2843.2843","title":"Pegifna Promotes Proliferation and Myeloid Differentiation In Human Hematopoietic Progenitors In Patients With Polycythemia Vera and Essential Thrombocythemia","display_name":"Pegifna Promotes Proliferation and Myeloid Differentiation In Human Hematopoietic Progenitors In Patients With Polycythemia Vera and Essential Thrombocythemia","publication_year":2013,"publication_date":"2013-11-15","ids":{"openalex":"https://openalex.org/W2570554665","doi":"https://doi.org/10.1182/blood.v122.21.2843.2843","mag":"2570554665"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v122.21.2843.2843","doi":"https://doi.org/10.1182/blood.v122.21.2843.2843","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v122.21.2843.2843","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5020638763","display_name":"Katherine Y. King","orcid":"https://orcid.org/0000-0002-5093-6005","observed_orcids":["https://orcid.org/0000-0002-5093-6005"]},"institutions":[{"id":"https://openalex.org/I181547552","display_name":"Baylor College of Medicine","ror":"https://ror.org/02pttbw34","country_code":"US","type":"education","lineage":["https://openalex.org/I181547552","https://openalex.org/I2801539370"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Katherine King","raw_affiliation_strings":["Stem Cells and Regenerative Medicine Center, Baylor College of Medicine, Houston, TX, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Stem Cells and Regenerative Medicine Center, Baylor College of Medicine, Houston, TX, USA,","institution_ids":["https://openalex.org/I181547552"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089969812","display_name":"Sabina I. Swierczek","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sabina Swierczek","raw_affiliation_strings":["Hematology Division, University of Utah, Salt Lake City, UT, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology Division, University of Utah, Salt Lake City, UT, USA,","institution_ids":["https://openalex.org/I223532165"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032745837","display_name":"Katie A. Matatall","orcid":"https://orcid.org/0009-0006-0496-2882","observed_orcids":["https://orcid.org/0009-0006-0496-2882"]},"institutions":[{"id":"https://openalex.org/I181547552","display_name":"Baylor College of Medicine","ror":"https://ror.org/02pttbw34","country_code":"US","type":"education","lineage":["https://openalex.org/I181547552","https://openalex.org/I2801539370"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Katie Matatall","raw_affiliation_strings":["Stem Cells and Regenerative Medicine Center, Baylor College of Medicine, Houston, TX, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Stem Cells and Regenerative Medicine Center, Baylor College of Medicine, Houston, TX, USA,","institution_ids":["https://openalex.org/I181547552"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109273666","display_name":"Kimberly Hickman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Kimberly Hickman","raw_affiliation_strings":["Division of Hematology, University of Utah, Salt Lake City, UT, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, University of Utah, Salt Lake City, UT, USA,","institution_ids":["https://openalex.org/I223532165"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074463940","display_name":"Margaret A. Goodell","orcid":"https://orcid.org/0000-0003-1111-2932","observed_orcids":["https://orcid.org/0000-0003-1111-2932"]},"institutions":[{"id":"https://openalex.org/I181547552","display_name":"Baylor College of Medicine","ror":"https://ror.org/02pttbw34","country_code":"US","type":"education","lineage":["https://openalex.org/I181547552","https://openalex.org/I2801539370"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Margaret A. Goodell","raw_affiliation_strings":["Stem Cells and Regenerative Medicine Center, Baylor College of Medicine, Houston, TX, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Stem Cells and Regenerative Medicine Center, Baylor College of Medicine, Houston, TX, USA,","institution_ids":["https://openalex.org/I181547552"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5042381475","display_name":"Josef T. Prchal","orcid":"https://orcid.org/0000-0002-8019-2940","observed_orcids":["https://orcid.org/0000-0002-8019-2940"]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Josef Prchal","raw_affiliation_strings":["Medicine, Hematology Div., University of Utah, Salt Lake City, UT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicine, Hematology Div., University of Utah, Salt Lake City, UT, USA","institution_ids":["https://openalex.org/I223532165"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5020638763","https://openalex.org/A5032745837","https://openalex.org/A5109273666"],"corresponding_institution_ids":["https://openalex.org/I181547552","https://openalex.org/I223532165"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.31280605,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"122","issue":"21","first_page":"2843","last_page":"2843"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/polycythemia-vera","display_name":"polycythemia vera","score":0.8859999775886536},{"id":"https://openalex.org/keywords/essential-thrombocythemia","display_name":"essential thrombocythemia","score":1.0},{"id":"https://openalex.org/keywords/myeloproliferative-neoplasms","display_name":"myeloproliferative neoplasms","score":0.9629999995231628},{"id":"https://openalex.org/keywords/pegylated-interferon-alpha","display_name":"pegylated interferon-alpha","score":0.9769999980926514},{"id":"https://openalex.org/keywords/hematopoietic-stem-cells","display_name":"hematopoietic stem cells","score":0.9150000214576721},{"id":"https://openalex.org/keywords/hematopoietic-progenitor-proliferation","display_name":"hematopoietic progenitor proliferation","score":0.8230000138282776},{"id":"https://openalex.org/keywords/myeloid-differentiation","display_name":"myeloid differentiation","score":0.9929999709129333},{"id":"https://openalex.org/keywords/jak2-v617f-mutation","display_name":"JAK2 V617F mutation","score":0.8519999980926514},{"id":"https://openalex.org/keywords/allelic-burden","display_name":"allelic burden","score":0.8849999904632568},{"id":"https://openalex.org/keywords/polyclonal-hematopoiesis","display_name":"polyclonal hematopoiesis","score":0.9200000166893005},{"id":"https://openalex.org/keywords/regulatory-t-cells","display_name":"regulatory T cells","score":0.8849999904632568},{"id":"https://openalex.org/keywords/hydroxyurea","display_name":"hydroxyurea","score":0.8209999799728394}],"concepts":[{"id":"https://openalex.org/C109159458","wikidata":"https://www.wikidata.org/wiki/Q919283","display_name":"Haematopoiesis","level":3,"score":0.7149178981781006},{"id":"https://openalex.org/C2778837598","wikidata":"https://www.wikidata.org/wiki/Q948318","display_name":"Polycythemia vera","level":2,"score":0.7024076581001282},{"id":"https://openalex.org/C2781057849","wikidata":"https://www.wikidata.org/wiki/Q1368780","display_name":"Essential thrombocythemia","level":3,"score":0.6361253261566162},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.6218351721763611},{"id":"https://openalex.org/C2779282312","wikidata":"https://www.wikidata.org/wiki/Q1956561","display_name":"Myeloid","level":2,"score":0.5843878984451294},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5837088823318481},{"id":"https://openalex.org/C2779727006","wikidata":"https://www.wikidata.org/wiki/Q426188","display_name":"FOXP3","level":3,"score":0.5328559875488281},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.5116100907325745},{"id":"https://openalex.org/C201750760","wikidata":"https://www.wikidata.org/wiki/Q1896218","display_name":"Progenitor cell","level":3,"score":0.48591604828834534},{"id":"https://openalex.org/C81089528","wikidata":"https://www.wikidata.org/wiki/Q5134986","display_name":"clone (Java method)","level":3,"score":0.4525735080242157},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.44107669591903687},{"id":"https://openalex.org/C2779788118","wikidata":"https://www.wikidata.org/wiki/Q1542410","display_name":"Thrombocytosis","level":3,"score":0.4125065803527832},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.2853245139122009},{"id":"https://openalex.org/C89560881","wikidata":"https://www.wikidata.org/wiki/Q101026","display_name":"Platelet","level":2,"score":0.11499974131584167},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.10685715079307556},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v122.21.2843.2843","doi":"https://doi.org/10.1182/blood.v122.21.2843.2843","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v122.21.2843.2843","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2586741499","https://openalex.org/W2346786161","https://openalex.org/W2524990707","https://openalex.org/W2983517120","https://openalex.org/W2496228640","https://openalex.org/W2564056222","https://openalex.org/W2206153557","https://openalex.org/W586512595","https://openalex.org/W2980145858","https://openalex.org/W2127237644"],"abstract_inverted_index":{"Abstract":[0],"The":[1],"myeloproliferative":[2],"neoplasms,":[3],"polycythemia":[4],"vera":[5],"(PV)":[6],"and":[7,37,61,181,231,235,310,502,514,544],"essential":[8],"thrombocythemia":[9],"(ET),":[10],"are":[11,80,221],"characterized":[12],"by":[13,116,374,498,518,549],"clonal":[14],"hematopoiesis":[15,276,288,497],"that":[16,127,159,172,248,300,344,473],"is":[17,192,303,490],"often":[18],"associated":[19],"with":[20,39,277,355,390],"a":[21,31,51,63,360,382,470,484,493],"JAK2V617F":[22,55,253,281,296],"mutation,":[23],"although":[24],"this":[25,190,218,418],"does":[26],"not":[27,530],"appear":[28],"to":[29,46,48,65,98,148,176,201,216,240,305,325,411,417,495],"be":[30,88,271],"disease-initiating":[32],"event.":[33],"Treatment":[34],"of":[35,74,109,136,179,225,233,259,280,330,347,365,377,396,405,432,443,460,476,504,538,542,556],"PV":[36,104,128,234,312,513,543],"ET":[38,515,545],"pegylated":[40],"interferon-alpha":[41],"(pegInf\u03b1)":[42],"has":[43,123],"been":[44,124],"shown":[45],"lead":[47],"hematological":[49],"remission,":[50],"decrease":[52,361],"in":[53,58,96,142,184,195,210,256,294,319,323,352,362,368,379,402,409,421,429,435,451,486],"the":[54,72,93,102,107,119,143,165,199,223,229,252,263,295,320,345,363,369,375,397,403,430,439,444,458,509],"allelic":[56,254,282,297],"burden":[57,255],"many":[59],"cases,":[60],"even":[62],"reversion":[64],"polyclonal":[66,275,287,496],"hematopoiesis.":[67],"Despite":[68],"promising":[69],"therapeutic":[70],"results,":[71],"mechanism":[73],"pegInf\u03b1-induced":[75],"remission":[76],"remains":[77],"elusive.":[78],"There":[79],"several":[81],"potential":[82,533],"mechanisms":[83,534],"through":[84],"which":[85,90,157,268,487],"pegInf\u03b1":[86,131,204,226,249,301,326,337,370,413,445,466,488,539],"may":[87],"acting,":[89],"include":[91],"stimulating":[92],"immune":[94],"system":[95],"order":[97,215],"more":[99,383],"effectively":[100],"suppress":[101],"aberrant":[103],"clones,":[105,516],"enhancing":[106],"activation":[108],"normal":[110,211,505],"hematopoietic":[111],"stem":[112],"cells":[113,140,378],"(HSCs),":[114],"or":[115,150,242,338,511,521],"selectively":[117],"suppressing":[118,508],"mutant":[120],"clones.":[121,313],"It":[122],"previously":[125],"reported":[126],"patients":[129,153,266,353,461],"on":[130,228],"have":[132,170,315],"an":[133,208,400,427,449,523],"increased":[134,177,351],"number":[135,346,431],"CD4+CD25+Foxp3+":[137],"T":[138],"regulatory":[139],"(Tregs)":[141],"peripheral":[144],"blood":[145],"as":[146],"compared":[147,239],"untreated":[149,243],"hydroxyurea":[151,241,339],"treated":[152,340,354,371,446],"(Riley":[154],"Blood,":[155],"2011),":[156],"suggests":[158,198],"PegIFNa":[160],"maybe":[161],"altering":[162],"immunity":[163],"against":[164],"mutated":[166],"clone.":[167],"However,":[168],"we":[169,220,246,342,358,424,456,468],"found":[171,343],"interferon":[173],"treatment":[174,227,250,302,489,541],"leads":[175],"proliferation":[178],"HSCs":[180,232,348,367,398],"myeloid-specific":[182],"differentiation":[183,503],"mice":[185],"(Baldridge":[186],"Nature,":[187],"2010).":[188],"If":[189],"finding":[191],"also":[193,206,425],"true":[194],"humans,":[196],"it":[197],"return":[200,494],"polyclonality":[202],"after":[203],"could":[205,270],"involve":[207],"increase":[209,401,420,428,450],"HSC":[212,321,386,422],"proliferation.":[213],"In":[214,388,415],"address":[217],"question,":[219],"studying":[222],"effects":[224,537],"Tregs":[230],"EV":[236],"patients,":[237,341,447],"when":[238],"patients.":[244,261],"Previously":[245],"showed":[247,399],"reduced":[251],"17":[257],"out":[258],"32":[260],"Of":[262],"13":[264],"female":[265],"for":[267,492,535,540],"clonality":[269],"assessed,":[272],"one":[273,285],"developed":[274,286],"three-fold":[278],"reduction":[279,293],"burden,":[283,298],"but":[284],"during":[289],"therapy":[290],"despite":[291],"no":[292],"suggesting":[299,381,448],"able":[304],"affect":[306],"both":[307],"pre-JAK2V617F":[308,510],"clones":[309],"JAK2V617F-positive":[311,512],"We":[314],"now":[316],"assessed":[317],"changes":[318],"population":[322],"response":[324,410],"treatment.":[327,414],"Upon":[328],"analysis":[329,395],"bone":[331,440],"marrow":[332,441],"samples":[333,442],"from":[334,438],"these":[335,391,481],"same":[336],"(CD45+CD34+CD38-)":[349],"was":[350,474],"pegInf\u03b1.":[356],"Further":[357],"saw":[359,426,469],"percent":[364],"quiescent":[366],"samples,":[372],"measured":[373],"percentage":[376],"G0,":[380],"actively":[384],"proliferating":[385],"population.":[387],"agreement":[389],"data,":[392],"our":[393],"RNA":[394,459],"expression":[404],"cell":[406,477,500,525],"cycle":[407],"genes":[408],"short-term":[412],"addition":[416],"apparent":[419],"proliferation,":[423],"colonies":[433],"formed":[434],"methocult":[436],"media":[437],"myeloid":[452],"specific":[453],"differentiation.":[454],"When":[455],"analyzed":[457],"who":[462],"had":[463],"received":[464],"long-term":[465],"treatment,":[467],"transcriptional":[471],"profile":[472],"indicative":[475],"death.":[478,526],"Taken":[479],"together,":[480],"data":[482],"suggest":[483],"model":[485],"allowing":[491],"inducing":[499,522],"division":[501],"HSCs,":[506],"while":[507],"possibly":[517],"promoting":[519],"apoptosis":[520],"immune-mediated":[524],"Our":[527],"findings":[528],"do":[529],"exclude":[531],"other":[532],"salutary":[536],"(see":[546],"accompanying":[547],"abstract":[548],"Swierczek":[550],"et":[551],"al).":[552],"Disclosures:":[553],"Swierczek:":[554],"University":[555],"Utah:":[557],"No":[558,562],"financial":[559,563],"compensation":[560,564],",":[561],"Patents":[565],"&":[566],"Royalties.":[567]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2017-01-13T00:00:00"}